This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA Safety Act could strengthen drug safety oversight
An editorial argues for the FDA Safety Act to create an independent center within the FDA to monitor drugs on the market and halt distribution or require studies when new risks emerge. It cites Vioxx and antidepressants as examples and urges an empowered panel free from industry bias to act decisively while preserving timely access to medicines.
MENTIONED IN THIS ARTICLE
Senate
Sens
Chuck Grassley
Lown
Christopher Dodd
FDA Safety Act
FDA
ECHE
Grassley
Senate Finance Committee
Drug Safety Oversight Board
Center For Drug Evaluation and Research
Oversight Board
U.S
Joseph Wilson
Bush
Iraq
Saddam Hussein
Niger
Dick Cheney
Wilson
New York Times
White House
Valerie Plame
CIA
Judith Miller
Matthew Cooper
Robert Novak
Novak
Plame
Miller
Cooper
Time Magazine
Fox
Genghis Khan
Tom Bloom
Oxford
Sinclair
Chicago
Theodore Roosevelt
Thomas Paine
Harriet Beecher Stowe
Roosevelt
George W. Bush
Republican Congress
Mary Chilton
Cedar Rapids
U.S. Department of Justice
J.A. Hynek